CrowdStrike Holdings Inc (CRWD)
304.07
+6.05
(+2.03%)
USD |
NASDAQ |
Apr 26, 16:00
304.07
0.00 (0.00%)
After-Hours: 20:00
CrowdStrike Holdings R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -- |
October 31, 2023 | -- |
July 31, 2023 | -- |
April 30, 2023 | -- |
January 31, 2023 | -- |
October 31, 2022 | -- |
July 31, 2022 | -- |
April 30, 2022 | -- |
January 31, 2022 | -- |
October 31, 2021 | -- |
July 31, 2021 | -- |
Date | Value |
---|---|
April 30, 2021 | -- |
January 31, 2021 | -- |
October 31, 2020 | -- |
July 31, 2020 | -- |
April 30, 2020 | -- |
January 31, 2020 | -- |
October 31, 2019 | -- |
July 31, 2019 | -- |
April 30, 2019 | -- |
January 31, 2019 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.